Adial Pharmaceuticals News - ADIL

Company Name	Stock Ticker Symbol	Market	Type
Adial Pharmaceuticals Inc	ADIL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.08	3.07%	2.69	05:20:29

Open Price	Low Price	High Price	Close Price	Prev Close
				2.61

more quote information »

Recent News

Date	Time	Source	Heading
4/10/2024	08:30	GLOBE	Adial Pharmaceuticals Announces Peer-Reviewed Publication..
4/02/2024	08:30	GLOBE	Adial Pharmaceuticals Reports 2023 Fiscal Year Financial..
3/01/2024	19:00	GLOBE	Adial Pharmaceuticals Announces Exercise of Warrants for..
2/28/2024	09:30	GLOBE	Adial Pharmaceuticals Awarded New Patent from the United..
2/14/2024	15:22	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/13/2024	09:15	GLOBE	Adial Pharmaceuticals Awarded New Patent Notice of Allowance..
1/25/2024	16:30	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/25/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/18/2024	16:15	EDGAR2	Form 8-K - Current report
1/18/2024	08:30	GLOBE	Adial Announces Appointment of Tony Goodman as Chief..
1/16/2024	16:17	EDGAR2	Form 8-K - Current report
1/12/2024	16:51	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/20/2023	09:00	GLOBE	Adial Pharmaceuticals Receives Final Reimbursement Payment..
12/12/2023	16:36	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/08/2023	11:08	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/29/2023	16:47	EDGAR2	Form 8-K - Current report
11/29/2023	16:05	GLOBE	Adial Pharmaceuticals Regains Compliance with Nasdaq Listing..
11/28/2023	16:10	EDGAR2	Form 8-K - Current report
11/24/2023	09:24	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/20/2023	07:46	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/2023	17:02	GLOBE	Adial Pharmaceuticals Reports Third Quarter 2023 Financial..
11/08/2023	16:05	EDGAR2	Form S-1 - General form for registration of securities under..
11/06/2023	06:14	EDGAR2	Form 8-K - Current report
10/31/2023	08:30	GLOBE	Adial Pharmaceuticals Chief Medical Officer and Key Opinion..
10/30/2023	17:24	EDGAR2	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/30/2023	17:18	EDGAR2	Form 8-K/A - Current report: [Amend]
10/30/2023	17:17	EDGAR2	Form NT 10-Q/A - Notification of inability to timely file..
10/25/2023	08:00	GLOBE	Addiction Experts Highlight the Need for..
10/24/2023	16:48	EDGAR2	Form 8-K - Current report
10/24/2023	16:30	GLOBE	Adial Pharmaceuticals Announces Closing of $4 Million..
10/20/2023	08:00	GLOBE	Adial Pharmaceuticals Announces $4 Million Private Placement..
10/19/2023	10:30	GLOBE	Adial Pharmaceuticals Awarded Notice of Allowance for Key..
10/18/2023	08:00	GLOBE	Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
10/03/2023	08:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/28/2023	07:00	GLOBE	Adial Pharmaceuticals to Host a Virtual Key Opinion Leader..
9/26/2023	21:08	EDGAR2	Form 8-K - Current report
9/21/2023	16:10	EDGAR2	Form 8-K - Current report
9/11/2023	06:03	EDGAR2	Form 8-K - Current report
9/05/2023	08:30	GLOBE	Adial Pharmaceuticals to Present at the H.C. Wainwright 25th..
8/28/2023	08:30	GLOBE	Adial Pharmaceuticals Chief Medical Officer and Key Opinion..
8/23/2023	08:45	EDGAR2	Form 8-K - Current report
8/23/2023	08:30	GLOBE	Adial Pharmaceuticals Regains Compliance with Nasdaq Listing..
8/21/2023	08:46	EDGAR2	Form 8-K - Current report
8/21/2023	08:30	GLOBE	Adial Pharmaceuticals Reports Second Quarter 2023 Financial..
8/21/2023	08:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/18/2023	17:05	EDGAR2	Form 8-K - Current report
8/15/2023	06:01	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
8/04/2023	08:30	EDGAR2	Form 8-K - Current report
8/04/2023	08:30	GLOBE	Adial Pharmaceuticals Announces Reverse Stock Split to..
7/13/2023	16:39	EDGAR2	Form S-1/A - General form for registration of securities..